Asian Phytoceuticals PCL (BKK: APCO)
Thailand
· Delayed Price · Currency is THB
4.920
-0.020 (-0.40%)
Dec 20, 2024, 4:36 PM ICT
Asian Phytoceuticals PCL Income Statement
Financials in millions THB. Fiscal year is January - December.
Millions THB. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Jan '20 Jan 1, 2020 | 2019 - 2015 |
Revenue | 226.67 | 292.76 | 250.38 | 223.35 | 247.73 | 247.65 | Upgrade
|
Revenue Growth (YoY) | -25.14% | 16.93% | 12.10% | -9.84% | 0.03% | -33.04% | Upgrade
|
Cost of Revenue | 46.7 | 57.25 | 47.94 | 46.26 | 52.87 | 51.81 | Upgrade
|
Gross Profit | 179.98 | 235.52 | 202.44 | 177.09 | 194.85 | 195.85 | Upgrade
|
Selling, General & Admin | 119.45 | 119.72 | 116.49 | 106.29 | 124.73 | 130.96 | Upgrade
|
Other Operating Expenses | -3.13 | -1.09 | -2.08 | -3.03 | -5.41 | -0.69 | Upgrade
|
Operating Expenses | 116.31 | 118.63 | 114.41 | 103.27 | 119.32 | 130.27 | Upgrade
|
Operating Income | 63.66 | 116.89 | 88.03 | 73.82 | 75.53 | 65.58 | Upgrade
|
Interest Expense | -1.73 | -0.66 | -0.57 | -0.86 | -0.48 | - | Upgrade
|
Interest & Investment Income | 14.42 | 15.22 | 12.41 | 10.31 | 4.41 | 4.64 | Upgrade
|
Earnings From Equity Investments | 1.46 | 1.26 | 0.61 | -0.28 | -0.01 | 0.79 | Upgrade
|
EBT Excluding Unusual Items | 77.81 | 132.72 | 100.48 | 82.98 | 79.45 | 71.01 | Upgrade
|
Gain (Loss) on Sale of Investments | 0.9 | 0.47 | -0.01 | 2.51 | 7.61 | 1.35 | Upgrade
|
Pretax Income | 78.71 | 133.18 | 100.47 | 85.49 | 87.07 | 72.36 | Upgrade
|
Income Tax Expense | 14.45 | 24.45 | 19.28 | 16.79 | 17.09 | 14.45 | Upgrade
|
Earnings From Continuing Operations | 64.25 | 108.74 | 81.2 | 68.7 | 69.98 | 57.9 | Upgrade
|
Minority Interest in Earnings | -0.67 | -1.24 | -0.28 | - | - | - | Upgrade
|
Net Income | 63.59 | 107.49 | 80.92 | 68.7 | 69.98 | 57.9 | Upgrade
|
Net Income to Common | 63.59 | 107.49 | 80.92 | 68.7 | 69.98 | 57.9 | Upgrade
|
Net Income Growth | -45.11% | 32.84% | 17.78% | -1.82% | 20.85% | -38.88% | Upgrade
|
Shares Outstanding (Basic) | 600 | 600 | 600 | 600 | 600 | 600 | Upgrade
|
Shares Outstanding (Diluted) | 600 | 600 | 600 | 600 | 600 | 600 | Upgrade
|
Shares Change (YoY) | -0.14% | 0.00% | -0.03% | -0.02% | 0.01% | 1.33% | Upgrade
|
EPS (Basic) | 0.11 | 0.18 | 0.13 | 0.11 | 0.12 | 0.10 | Upgrade
|
EPS (Diluted) | 0.11 | 0.18 | 0.13 | 0.11 | 0.12 | 0.10 | Upgrade
|
EPS Growth | -45.03% | 32.84% | 17.82% | -1.80% | 20.83% | -39.69% | Upgrade
|
Free Cash Flow | 56.62 | 120.72 | 99.86 | 83.22 | 82.57 | 70.51 | Upgrade
|
Free Cash Flow Per Share | 0.09 | 0.20 | 0.17 | 0.14 | 0.14 | 0.12 | Upgrade
|
Dividend Per Share | 0.180 | 0.180 | 0.155 | 0.123 | 0.120 | 0.095 | Upgrade
|
Dividend Growth | 16.13% | 16.13% | 25.61% | 2.83% | 26.32% | -38.67% | Upgrade
|
Gross Margin | 79.40% | 80.45% | 80.85% | 79.29% | 78.66% | 79.08% | Upgrade
|
Operating Margin | 28.09% | 39.93% | 35.16% | 33.05% | 30.49% | 26.48% | Upgrade
|
Profit Margin | 28.05% | 36.72% | 32.32% | 30.76% | 28.25% | 23.38% | Upgrade
|
Free Cash Flow Margin | 24.98% | 41.24% | 39.88% | 37.26% | 33.33% | 28.47% | Upgrade
|
EBITDA | 70.01 | 123.69 | 94.84 | 81.48 | 87.51 | 79.04 | Upgrade
|
EBITDA Margin | 30.89% | 42.25% | 37.88% | 36.48% | 35.32% | 31.91% | Upgrade
|
D&A For EBITDA | 6.35 | 6.8 | 6.81 | 7.66 | 11.97 | 13.46 | Upgrade
|
EBIT | 63.66 | 116.89 | 88.03 | 73.82 | 75.53 | 65.58 | Upgrade
|
EBIT Margin | 28.09% | 39.93% | 35.16% | 33.05% | 30.49% | 26.48% | Upgrade
|
Effective Tax Rate | 18.36% | 18.36% | 19.19% | 19.64% | 19.63% | 19.97% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.